Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Doi

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Neurosurgery|June 21, 2011
Immunoliposomal drug-delivery system targeting lectin-like oxidized low-density lipoprotein receptor-1 for carotid plaque lesions in ratsAtsushi Saito, Hiroaki Shimizu, Yusuke Doi, et al.
Cancer Science|June 24, 2017
Modulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse modelTaro Shimizu, Amr S Abu Lila, Miho Nishio, et al.
Toxicology and Applied Pharmacology|October 22, 2017
Liposomalization of oxaliplatin induces skin accumulation of it, but negligible skin toxicityKentaro Nishida, Misaki Kashiwagi, Shunsuke Shiba, et al.
Journal of Radiation Research|January 26, 2008
Quantitative analysis of isolated and clustered DNA damage induced by gamma-rays, carbon ion beams, and iron ion beamsHiroaki Terato, Ruri Tanaka, Yusuke Nakaarai, et al.
Forensic Science International|July 9, 2004
A new 39-plex analysis method for SNPs including 15 blood group lociSachiyo Inagaki, Yuji Yamamoto, Yusuke Doi, et al.
Genes & Development|December 7, 2007
Mechanism of mRNA deadenylation: evidence for a molecular interplay between translation termination factor eRF3 and mRNA deadenylasesYuji Funakoshi, Yusuke Doi, Nao Hosoda, et al.
Drug Delivery and Translational Research|March 20, 2015
Improved intratumoral delivery of PEG-coated siRNA-lipoplexes by combination with metronomic S-1 dosing in a murine solid tumor modelTatsuaki Tagami, Amr S Abu Lila, Mariko Matsunaga, et al.
Molecular Pharmaceutics|December 30, 2017
Intratumoral Visualization of Oxaliplatin within a Liposomal Formulation Using X-ray Fluorescence SpectrometryHidenori Ando, Amr S Abu Lila, Masao Tanaka, et al.
Journal of Pharmaceutical Sciences|July 11, 2021
Liposomalization of Oxaliplatin Exacerbates the Non-Liposomal Formulation-Induced Decrease of Sweet Taste Sensitivity in RatsKeisuke Mogi, Ikumi Kamiya, Aimi Makino, et al.
Journal of Medical Virology|May 7, 2024
Period prevalence of uveitis in human T-lymphotropic virus 1 carriers versus noncarriers in a highly endemic area: The Nagasaki Islands StudyJun Miyata, Hirotomo Yamanashi, Yoshinori Dake, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Neurosurgery|June 21, 2011
Immunoliposomal drug-delivery system targeting lectin-like oxidized low-density lipoprotein receptor-1 for carotid plaque lesions in ratsAtsushi Saito, Hiroaki Shimizu, Yusuke Doi, et al.
Cancer Science|June 24, 2017
Modulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse modelTaro Shimizu, Amr S Abu Lila, Miho Nishio, et al.
Toxicology and Applied Pharmacology|October 22, 2017
Liposomalization of oxaliplatin induces skin accumulation of it, but negligible skin toxicityKentaro Nishida, Misaki Kashiwagi, Shunsuke Shiba, et al.
Journal of Radiation Research|January 26, 2008
Quantitative analysis of isolated and clustered DNA damage induced by gamma-rays, carbon ion beams, and iron ion beamsHiroaki Terato, Ruri Tanaka, Yusuke Nakaarai, et al.
Forensic Science International|July 9, 2004
A new 39-plex analysis method for SNPs including 15 blood group lociSachiyo Inagaki, Yuji Yamamoto, Yusuke Doi, et al.
Genes & Development|December 7, 2007
Mechanism of mRNA deadenylation: evidence for a molecular interplay between translation termination factor eRF3 and mRNA deadenylasesYuji Funakoshi, Yusuke Doi, Nao Hosoda, et al.
Drug Delivery and Translational Research|March 20, 2015
Improved intratumoral delivery of PEG-coated siRNA-lipoplexes by combination with metronomic S-1 dosing in a murine solid tumor modelTatsuaki Tagami, Amr S Abu Lila, Mariko Matsunaga, et al.
Molecular Pharmaceutics|December 30, 2017
Intratumoral Visualization of Oxaliplatin within a Liposomal Formulation Using X-ray Fluorescence SpectrometryHidenori Ando, Amr S Abu Lila, Masao Tanaka, et al.
Journal of Pharmaceutical Sciences|July 11, 2021
Liposomalization of Oxaliplatin Exacerbates the Non-Liposomal Formulation-Induced Decrease of Sweet Taste Sensitivity in RatsKeisuke Mogi, Ikumi Kamiya, Aimi Makino, et al.
Journal of Medical Virology|May 7, 2024
Period prevalence of uveitis in human T-lymphotropic virus 1 carriers versus noncarriers in a highly endemic area: The Nagasaki Islands StudyJun Miyata, Hirotomo Yamanashi, Yoshinori Dake, et al.
Pageof 4